rtanasa

We've been seeing terrible performance from Opus 5, so it does look like a plateau. They most certainly reached the marginal returns realm.

We're working on Inflexa - https://github.com/inflexa-ai/inflexa

It's a local-first CLI for reproducible biological analysis, with provenance tracked on every step. If you're a bioinformatician, we'd absolutely love to hear your feedback!